Literature DB >> 30474839

Assessing Functional Roles of the Senescence-Associated Secretory Phenotype (SASP).

Nicolas Malaquin1, Véronique Tu1, Francis Rodier2,3.   

Abstract

Cellular senescence is linked to many normal biological processes, including tumor suppression, development, and wound healing, but it is also associated with age-related pathologies such as cancer progression. Numerous functions of senescent cells depend on their ability to secrete bioactive molecules, a characteristic termed the senescence-associated secretory phenotype (SASP). Although the SASP is generally described as proinflammatory, its true microenvironmental impact and composition may vary according to cell types (i.e., fibroblasts/epithelial, normal/cancerous) and senescence-triggering stimuli (i.e., replicative senescence, DNA damage-induced senescence, oncogene-induced senescence). The SASP reinforces autocrine cell-autonomous functions such as the senescence-associated proliferation arrest, but also mediates potent paracrine, non-cell-autonomous effects. In a paracrine manner, senescent cells influence the remodeling of surrounding tissues and the biology of adjacent cells, including modulation of proliferation and migration/invasion, reinforcement/induction of peripheral senescence, and immune cell activity or recruitment. Overall, the complexity of the context-dependent SASP composition and varied microenvironmental impact demonstrate the importance of properly assessing SASP functions directly on target cells. In this chapter, we focus on experimental approaches to evaluate the impact of SASP on the proliferation and migration/invasion capacities of target cancer cells. These techniques, with combined supplemental notes, will facilitate the assessment of novel functions of senescent cells on their microenvironment, and can be easily adapted beyond the use of the presented SASP-cancer scenario.

Entities:  

Keywords:  Cell transformation; Microenvironment; Migration/invasion assay; Proliferation assay; Secretome; Secretory phenotype; Senescence

Mesh:

Year:  2019        PMID: 30474839     DOI: 10.1007/978-1-4939-8931-7_6

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  6 in total

1.  New Horizons in the Treatment of Age-Associated Obesity, Sarcopenia and Osteoporosis.

Authors:  Alexander Kalinkovich; Maria Becker; Gregory Livshits
Journal:  Drugs Aging       Date:  2022-07-04       Impact factor: 4.271

2.  Investigating the Benefit of Combined Androgen Modulation and Hypofractionation in Prostate Cancer.

Authors:  Alice Zamagni; Michele Zanoni; Michela Cortesi; Chiara Arienti; Sara Pignatta; Antonella Naldini; Anna Sarnelli; Antonino Romeo; Anna Tesei
Journal:  Int J Mol Sci       Date:  2020-11-10       Impact factor: 5.923

Review 3.  Treg and Oligoclonal Expansion of Terminal Effector CD8+ T Cell as Key Players in Multiple Myeloma.

Authors:  Douglas E Joshua; Slavica Vuckovic; James Favaloro; Ka Hei Aleks Lau; Shihong Yang; Christian E Bryant; John Gibson; Phoebe Joy Ho
Journal:  Front Immunol       Date:  2021-02-23       Impact factor: 7.561

Review 4.  Tieing together loose ends: telomere instability in cancer and aging.

Authors:  Gustavo Borges; Mélanie Criqui; Lea Harrington
Journal:  Mol Oncol       Date:  2022-08-16       Impact factor: 7.449

5.  Doxorubicin-induced senescence promotes stemness and tumorigenicity in EpCAM-/CD133- nonstem cell population in hepatocellular carcinoma cell line, HuH-7.

Authors:  Mustafa Karabicici; Sena Alptekin; Zeynep Fırtına Karagonlar; Esra Erdal
Journal:  Mol Oncol       Date:  2021-03-08       Impact factor: 6.603

6.  Involvement of Klotho, TNF‑α and ADAMs in radiation‑induced senescence of renal epithelial cells.

Authors:  Da Yeon Kim; Minyoung Lee; Eun Ju Kim
Journal:  Mol Med Rep       Date:  2020-11-12       Impact factor: 2.952

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.